Overview

Drug-drug Interaction Study of Rifampin and Anaprazole Sodium

Status:
NOT_YET_RECRUITING
Trial end date:
2027-07-21
Target enrollment:
Participant gender:
Summary
A drug-drug interaction study designed to evaluate the drug-drug interaction between rifampin capsules and anaprazole sodium enteric-coated tablets in healthy adult subjects
Phase:
PHASE4
Details
Lead Sponsor:
Xuanzhu Biopharmaceutical Co., Ltd.
Treatments:
Rifampin